Harrow, Inc. Operating Lease Right-of-Use Assets
Harrow, Inc. (HROW) had Operating Lease Right-of-Use Assets of $7.39 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-10
- 2026-06-30: Operating Lease, Right-of-Use Asset $7.39M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $7.59M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $7.78M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $7.97M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $7.39M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $7.59M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $7.78M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $7.97M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $8.15M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $8.34M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $8.55M 10-K · filed 2026-03-02 |
| 2024-09-30 | $9.38M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $6.77M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $6.97M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $6.79M 10-K · filed 2025-03-27 |
| 2023-09-30 | $6.97M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $7.16M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $7.34M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $7.51M 10-K · filed 2024-03-19 |
| 2022-09-30 | $7.69M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $7.86M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $6.85M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $5.93M 10-K · filed 2023-03-23 |
| 2021-09-30 | $4.62M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $4.75M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $6.65M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $6.80M 10-K · filed 2022-03-10 |
| 2020-09-30 | $6.95M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $6.26M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $6.43M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $6.56M 10-K · filed 2021-03-08 |
| 2019-09-30 | $5.94M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $6.07M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $6.20M 10-Q · filed 2019-05-09 |
| 2019-01-02 | $6.33M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $2.11M 10-K · filed 2019-03-12 |
| 2018-09-30 | $2.30M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $2.30M 10-Q · filed 2018-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |